יום שלישי, 12 באפריל, 2016

 

Boehringer-Ingelheim- Lunch Session
Dabigatran 2016: Innovation in Anticoagulation Care
Hall H 

AstraZeneca – Lunch Session

Prolonged DAPT – Where Do We Stand Post PEGASUS & DAPT Trials?

Hall I

Sanofi – Lunch Session
PCSK9 Inhibition : Heralding a New Era for Prevention of Cardiovascular
Disease
Hall J
יום רביעי, 13 באפריל, 2016

Pfizer – Lunch Session

From RCTs and RWD to your Own Practical Choices

Hall H

Novartis – Lunch Session

EnTRESTo – Redefine Heart Failure Treatment

Hall I

Bayer – Lunch Session

Xarelto – Confidence from Evidence and Real World Experience
Adempas – From PE to CTEPHe

Hall J